Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CI · against 44 other Healthcare companies of similar size
Ranked #1 of 45 · scores higher than 100% of peers
Bars: peers in each 10-point band of the valuation score8 peers with a valuation score of 80–89, including CI · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | CI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 43 reported | 8.2% | 3.1% | 100% | 30% | |
| EBITDA yieldHigher is better · 46 reported | 12.4% | 6.0% | 100% | 50% | |
| Free cash flow yieldHigher is better · 34 reported | 11.7% | 3.5% | 100% | 20% | |
| Book yieldHigher is better · 43 reported | 54.7% | 19.3% | 93% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 78.1B USD | 89 | 60 | |
| 2 | 108.6B USD | 88 | 66 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score